Paper25225409
Engagement of myelomonocytic Siglecs by tumor-associated ligands modulates the innate immune response to cancer.
Läubli H and 13 others. Proc Natl Acad Sci U S A, 2014. Cited by 201 papers, by iCite.
Cite this record
ConductScience Library. Engagement of myelomonocytic Siglecs by tumor-associated ligands modulates the innate immune response to cancer. Papers, record 25225409. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/25225409
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics20
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antigens, CD | Major topic |
| Antigens, Differentiation, B-Lymphocyte | Major topic |
| Immunity, Innate | Major topic |
| Neoplasms | Major topic |
| Sialic Acid Binding Immunoglobulin-like Lectins | Major topic |
| Animals | |
| Carcinoma, Non-Small-Cell Lung | |
| Cell Line, Tumor | |
| Female | |
| Humans | |
| Ligands | |
| Lung Neoplasms | |
| Male | |
| Mice | |
| Mice, Knockout | |
| Mice, Transgenic | |
| Monocytes | |
| Neutrophil Activation | |
| Polymorphism, Single Nucleotide | |
| Tumor Microenvironment |
Source PubMed
Grants9
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| R01CA14176 | NCI NIH HHS | United States | PubMed | PubMed | |
| R01CA38701 | NCI NIH HHS | United States | R01CA038701 | PubMed and NIH | NIH RePORTER |
| R01 CA141769 | NCI NIH HHS | United States | R01CA141769 | PubMed and NIH | NIH RePORTER |
| R01060691 | PHS HHS | United States | PubMed | PubMed | |
| P30CA022453 | NCI NIH HHS | United States | P30CA022453 | PubMed and NIH | NIH RePORTER |
| N01 PC035145 | NCI NIH HHS | United States | N01PC035145 | PubMed | NIH RePORTER |
| P30 CA023100 | NCI NIH HHS | United States | P30CA023100 | PubMed and NIH | NIH RePORTER |
| R01 CA038701 | NCI NIH HHS | United States | R01CA038701 | PubMed and NIH | NIH RePORTER |
| P30 CA022453 | NCI NIH HHS | United States | P30CA022453 | PubMed and NIH | NIH RePORTER |
References46
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 15342420 | Expression of complement factor H by lung cancer cells: effects on the activation of the alternative pathway of complement. | Cancer Res | 2004 | https://conductscience.org/library/papers/15342420 | PubMed |
| 2 | 23329041 | Neutralizing tumor-promoting chronic inflammation: a magic bullet? | Science | 2013 | https://conductscience.org/library/papers/23329041 | PubMed |
| 3 | 69628 | Selective radioactive labeling of cell surface sialoglycoproteins by periodate-tritiated borohydride. | J Biol Chem | 1977 | https://conductscience.org/library/papers/69628 | PubMed |
| 4 | 16682635 | Loss of Siglec expression on T lymphocytes during human evolution. | Proc Natl Acad Sci U S A | 2006 | https://conductscience.org/library/papers/16682635 | PubMed |
| 5 | 15292262 | Negative regulation of T cell receptor signaling by Siglec-7 (p70/AIRM) and Siglec-9. | J Biol Chem | 2004 | https://conductscience.org/library/papers/15292262 | PubMed |
| 6 | 19178537 | Siglec-8 on human eosinophils and mast cells, and Siglec-F on murine eosinophils, are functionally related inhibitory receptors. | Clin Exp Allergy | 2009 | https://conductscience.org/library/papers/19178537 | PubMed |
| 7 | 24154716 | Inflammation-induced cancer: crosstalk between tumours, immune cells and microorganisms. | Nat Rev Cancer | 2013 | https://conductscience.org/library/papers/24154716 | PubMed |
| 8 | 22444630 | Regulatory circuits mediated by lectin-glycan interactions in autoimmunity and cancer. | Immunity | 2012 | https://conductscience.org/library/papers/22444630 | PubMed |
| 9 | 24045940 | Binding of the sialic acid-binding lectin, Siglec-9, to the membrane mucin, MUC1, induces recruitment of β-catenin and subsequent cell growth. | J Biol Chem | 2013 | https://conductscience.org/library/papers/24045940 | PubMed |
| 10 | 14708027 | Tumour-educated macrophages promote tumour progression and metastasis. | Nat Rev Cancer | 2004 | https://conductscience.org/library/papers/14708027 | PubMed |
| 11 | 21436444 | Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion. | Science | 2011 | https://conductscience.org/library/papers/21436444 | PubMed |
| 12 | 20956342 | Sialylation of 3-methylcholanthrene-induced fibrosarcoma determines antitumor immune responses during immunoediting. | J Immunol | 2010 | https://conductscience.org/library/papers/20956342 | PubMed |
| 13 | 10801860 | Cloning, characterization, and phylogenetic analysis of siglec-9, a new member of the CD33-related group of siglecs. Evidence for co-evolution with sialic acid synthesis pathways. | J Biol Chem | 2000 | https://conductscience.org/library/papers/10801860 | PubMed |
| 14 | 10764831 | Siglec-7: a sialic acid-binding lectin of the immunoglobulin superfamily. | Glycobiology | 2000 | https://conductscience.org/library/papers/10764831 | PubMed |
| 15 | 19076345 | Basic and clinical immunology of Siglecs. | Ann N Y Acad Sci | 2008 | https://conductscience.org/library/papers/19076345 | PubMed |
| 16 | 23029261 | Engagement of Siglec-7 receptor induces a pro-inflammatory response selectively in monocytes. | PLoS One | 2012 | https://conductscience.org/library/papers/23029261 | PubMed |
| 17 | 22467657 | Colonic epithelial cells express specific ligands for mucosal macrophage immunosuppressive receptors siglec-7 and -9. | J Immunol | 2012 | https://conductscience.org/library/papers/22467657 | PubMed |
| 18 | 23485549 | Modulation of neutrophil granulocytes in the tumor microenvironment: mechanisms and consequences for tumor progression. | Semin Cancer Biol | 2013 | https://conductscience.org/library/papers/23485549 | PubMed |
| 19 | 20733319 | A novel function of Siglec-9 A391C polymorphism on T cell receptor signaling. | Int Arch Allergy Immunol | 2011 | https://conductscience.org/library/papers/20733319 | PubMed |
| 20 | 24145038 | Binding of a sialic acid-recognizing lectin Siglec-9 modulates adhesion dynamics of cancer cells via calpain-mediated protein degradation. | J Biol Chem | 2013 | https://conductscience.org/library/papers/24145038 | PubMed |
Cited by140
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 201 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42919624 | Siglec-15 and its glycan ligands in tumor-associated macrophage biology and immunotherapy. | J Immunother Cancer | 2026 | https://conductscience.org/library/papers/42919624 | PubMed |
| 42427411 | Sialic acid-modified phosphorene for low-necrosis and targeted drug delivery in breast cancer. | RSC Adv | 2026 | https://conductscience.org/library/papers/42427411 | PubMed |
| 42277951 | Roles of neutrophil extracellular traps in cancer immunotherapy resistance and therapeutic targeting. | Biomark Res | 2026 | https://conductscience.org/library/papers/42277951 | PubMed |
| 42153609 | Sialylation in Colorectal Cancer Rewires Antitumor Immunity at the Peritoneal Metastatic Site. | Eur J Immunol | 2026 | https://conductscience.org/library/papers/42153609 | PubMed |
| 41402487 | Antibody-lectin chimeras for glyco-immune checkpoint blockade. | Nat Biotechnol | 2026 | https://conductscience.org/library/papers/41402487 | PubMed |
| 41398201 | Siglec-14-LGALS3BP glycoimmune axis shapes tumor-associated macrophage polarization and confers poor outcome in colorectal cancer. | NPJ Precis Oncol | 2025 | https://conductscience.org/library/papers/41398201 | PubMed |
| 41390763 | HIV-induced sialoglycans on infected CD4+ T cells promote immune evasion from myeloid cell-mediated killing. | Nat Commun | 2025 | https://conductscience.org/library/papers/41390763 | PubMed |
| 41311955 | Molecular Insights into the Engagement of High-Affinity Sialylated Ligands to Human CD22. | JACS Au | 2025 | https://conductscience.org/library/papers/41311955 | PubMed |
| 41303731 | Decoding SIGLEC12 in Bladder Cancer: In Silico Profiling of Expression, Tumor-Immune Interactions, and Prognostic Impact. | Medicina (Kaunas) | 2025 | https://conductscience.org/library/papers/41303731 | PubMed |
| 41215973 | Increase of Inhibitory Siglec receptors on T cells mitigates severe immune reactions during acute viral infections. | PNAS Nexus | 2025 | https://conductscience.org/library/papers/41215973 | PubMed |
| 41154604 | Dysregulated Sialylation in Cancer: From Immunosuppressive Microenvironment to Siglec-Targeted Therapeutics. | Biomolecules | 2025 | https://conductscience.org/library/papers/41154604 | PubMed |
| 40892920 | Tumor-expressed GPNMB orchestrates Siglec-9+ TAM polarization and EMT to promote metastasis in triple-negative breast cancer. | Proc Natl Acad Sci U S A | 2025 | https://conductscience.org/library/papers/40892920 | PubMed |
| 40874587 | Targeting Myeloid Cells for Cancer Immunotherapy. | Cancer Immunol Res | 2025 | https://conductscience.org/library/papers/40874587 | PubMed |
| 40533266 | Tumor glyco-immunology, glyco-immune checkpoints and immunotherapy. | J Immunother Cancer | 2025 | https://conductscience.org/library/papers/40533266 | PubMed |
| 40500109 | IL-4-STAT6-induced high Siglec-G/10 expression aggravates the severe immune suppressive tumor microenvironment and impedes the efficacy of immunotherapy in head and neck squamous cell carcinoma. | J Immunother Cancer | 2025 | https://conductscience.org/library/papers/40500109 | PubMed |
| 40333992 | The inhibitory receptor Siglec-E controls antigen-presenting cell activation and T cell-mediated transplant rejection. | Sci Transl Med | 2025 | https://conductscience.org/library/papers/40333992 | PubMed |
| 40191202 | Targeting tumor-associated macrophages in colon cancer: mechanisms and therapeutic strategies. | Front Immunol | 2025 | https://conductscience.org/library/papers/40191202 | PubMed |
| 40076855 | Insights on the Role of Sialic Acids in Acute Lymphoblastic Leukemia in Children. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40076855 | PubMed |
| 39813162 | Proximity Labeling and Genetic Screening Reveal that DSG2 is a Counter Receptor of Siglec-9 and Suppresses Macrophage Phagocytosis. | Adv Sci (Weinh) | 2025 | https://conductscience.org/library/papers/39813162 | PubMed |
| 39755580 | Targeting Siglec-E facilitates tumor vaccine-induced antitumor immunity in renal carcinoma. | J Immunother Cancer | 2025 | https://conductscience.org/library/papers/39755580 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| SIGLEC9 | 27180 | PubTator's text mining | https://conductscience.org/library/genes/27180 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/25225409
GET https://conductscience.org/api/papers/v1/25225409/references?page=2